Corrigendum to "The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling" [Metab Clin Exp 85 (2018) 59-75]

Gaia Botteri; Laia Salvadó; Anna Gumà; D Lee Hamilton; Paul J Meakin; Gemma Montagut; Michael L J Ashford; Victoria Ceperuelo-Mallafré; Sonia Fernández-Veledo; Joan Vendrell; María Calderón-Dominguez; Dolors Serra; Laura Herrero; Javier Pizarro; Emma Barroso; Xavier Palomer; Manuel Vázquez-Carrera

doi:10.1016/j.metabol.2019.04.009

Corrigendum to "The BACE1 product sAPPβ induces ER stress and inflammation and impairs insulin signaling" [Metab Clin Exp 85 (2018) 59-75]

Metabolism. 2019 Jul:96:101-102. doi: 10.1016/j.metabol.2019.04.009. Epub 2019 Apr 18.

Authors

Gaia Botteri¹, Laia Salvadó¹, Anna Gumà², D Lee Hamilton³, Paul J Meakin³, Gemma Montagut³, Michael L J Ashford³, Victoria Ceperuelo-Mallafré⁴, Sonia Fernández-Veledo⁴, Joan Vendrell⁴, María Calderón-Dominguez⁵, Dolors Serra⁵, Laura Herrero⁵, Javier Pizarro¹, Emma Barroso¹, Xavier Palomer¹, Manuel Vázquez-Carrera⁶

Affiliations

¹ Pharmacology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Spain; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain; Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Barcelona, Spain.
² Institut de Biomedicina de la Universitat de Barcelona (IBUB), Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Barcelona, Spain.
³ Division of Molecular and Clinical Medicine, School of Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
⁴ Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain; Hospital Universitari de Tarragona Joan XXIII, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Tarragona, Spain.
⁵ Institut de Biomedicina de la Universitat de Barcelona (IBUB), Spain; Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Spain; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Barcelona, Spain.
⁶ Pharmacology Unit, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Spain; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain; Institut de Recerca Sant Joan de Déu (IR-SJD), Esplugues de Llobregat, Barcelona, Spain. Electronic address: [email protected].

PMID: 31005247
DOI: 10.1016/j.metabol.2019.04.009

No abstract available

Publication types

Published Erratum

Publication types

Grants and funding